First Time Loading...

Abbvie Inc
NYSE:ABBV

Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist
Price: 168.28 USD -0.74%
Updated: Apr 24, 2024

Abbvie Inc
Free Cash Flow

Last Value
3-Years CAGR
5-Years CAGR
Quarterly
Annual
TTM
|

Abbvie Inc
Free Cash Flow Peer Comparison

Comparables:
GILD
AMGN
VRTX
REGN
SGEN

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Abbvie Inc
NYSE:ABBV
Free Cash Flow
$22.1B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
14%
Gilead Sciences Inc
NASDAQ:GILD
Free Cash Flow
$7.4B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
10%
Amgen Inc
NASDAQ:AMGN
Free Cash Flow
$7.4B
CAGR 3-Years
-9%
CAGR 5-Years
-7%
CAGR 10-Years
3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Free Cash Flow
$3.3B
CAGR 3-Years
3%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Free Cash Flow
$3.7B
CAGR 3-Years
22%
CAGR 5-Years
15%
CAGR 10-Years
24%
Seagen Inc
NASDAQ:SGEN
Free Cash Flow
-$701.2m
CAGR 3-Years
N/A
CAGR 5-Years
-31%
CAGR 10-Years
N/A

See Also

What is Abbvie Inc's Free Cash Flow?
Free Cash Flow
22.1B USD

Based on the financial report for Dec 31, 2023, Abbvie Inc's Free Cash Flow amounts to 22.1B USD.

What is Abbvie Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
14%

Over the last year, the Free Cash Flow growth was -9%. The average annual Free Cash Flow growth rates for Abbvie Inc have been 10% over the past three years , 12% over the past five years , and 14% over the past ten years .